301520 万邦医药
已收盘 07-17 15:00:00
资讯
新帖
简况
万邦医药股价下跌1.95% 公司澄清与辉瑞、阿斯利康无合作关系
金融界 · 07-15 18:30
万邦医药股价下跌1.95% 公司澄清与辉瑞、阿斯利康无合作关系
万邦医药:截止2025年6月10日,公司的股东人数为12,206户
证券之星 · 06-17
万邦医药:截止2025年6月10日,公司的股东人数为12,206户
【CRO概念震荡走低 联化科技跌停】CRO概念震荡走低,联化科技跌停,万邦医药、河化股份、翰宇药业、睿智医药、昭衍新药等跟跌。
金融界 · 06-11
【CRO概念震荡走低 联化科技跌停】CRO概念震荡走低,联化科技跌停,万邦医药、河化股份、翰宇药业、睿智医药、昭衍新药等跟跌。
万邦医药收盘上涨8.99%,滚动市盈率44.32倍,总市值30.00亿元
金融界 · 06-09
万邦医药收盘上涨8.99%,滚动市盈率44.32倍,总市值30.00亿元
万邦医药:公司有为改善干眼症的麦角硫因洗眼液项目提供临床功效试验服务
证券之星 · 05-16
万邦医药:公司有为改善干眼症的麦角硫因洗眼液项目提供临床功效试验服务
【万邦医药:与仅三生物在麦角硫因方面有临床项目合作】万邦医药在互动平台表示,公司与仅三生物在麦角硫因方面有临床项目合作,公司为仅三生物研发的产品提供功效性验证临床服务。
金融界 · 05-16
【万邦医药:与仅三生物在麦角硫因方面有临床项目合作】万邦医药在互动平台表示,公司与仅三生物在麦角硫因方面有临床项目合作,公司为仅三生物研发的产品提供功效性验证临床服务。
万邦医药:公司研究了麦角硫因的潜在多种功效
证券之星 · 05-16
万邦医药:公司研究了麦角硫因的潜在多种功效
万邦医药:公司与仅三生物在麦角硫因方面有临床项目合作
证券之星 · 05-16
万邦医药:公司与仅三生物在麦角硫因方面有临床项目合作
万邦医药收盘下跌2.27%,滚动市盈率35.14倍,总市值23.79亿元
金融界 · 04-28
万邦医药收盘下跌2.27%,滚动市盈率35.14倍,总市值23.79亿元
万邦医药(301520.SZ)发布2024年度业绩,归母净利润8553.07万元,下降20.87%
智通财经网 · 04-21
万邦医药(301520.SZ)发布2024年度业绩,归母净利润8553.07万元,下降20.87%
万邦医药(301520.SZ)发布一季度业绩,归母净利润1184.93万元,下降60.09%
智通财经 · 04-21
万邦医药(301520.SZ)发布一季度业绩,归母净利润1184.93万元,下降60.09%
万邦医药最新公告:证券事务代表杨婷因个人原因辞职
证券之星 · 02-28
万邦医药最新公告:证券事务代表杨婷因个人原因辞职
万邦医药上涨5.09%,报44.99元/股
金融界 · 02-25
万邦医药上涨5.09%,报44.99元/股
万邦医药:公司在药物研发过程中暂未使用AI技术
证券之星 · 02-14
万邦医药:公司在药物研发过程中暂未使用AI技术
万邦医药:关于加大现金分红及转增股本的具体方案将综合考虑后制定
证券之星 · 01-14
万邦医药:关于加大现金分红及转增股本的具体方案将综合考虑后制定
万邦医药:公司临床试验研究及药学研究的项目中有涉及呼吸道感染相关的药品,例如氨茶碱片等,但公司不涉及生产及销售
证券之星 · 01-09
万邦医药:公司临床试验研究及药学研究的项目中有涉及呼吸道感染相关的药品,例如氨茶碱片等,但公司不涉及生产及销售
1月2日万邦医药现1笔折价18.69%的大宗交易 合计成交1833.2万元
证券之星 · 01-02
1月2日万邦医药现1笔折价18.69%的大宗交易 合计成交1833.2万元
万邦医药1月2日现1笔大宗交易 成交金额1833.2万元
新浪证券-红岸工作室 · 01-02
万邦医药1月2日现1笔大宗交易 成交金额1833.2万元
加载更多
公司概况
公司名称:
安徽万邦医药科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2023-09-25
主营业务:
安徽万邦医药科技股份有限公司的主营业务是为医药企业和其他医药研发机构提供专业化医药研发外包服务。公司的主要产品是临床试验现场管理(SMO)、生物样本分析(BA)、数据管理与统计分析(DM/ST)、处方工艺研究、质量研究、稳定性研究。
发行价格:
67.88
{"stockData":{"symbol":"301520","market":"SZ","secType":"STK","nameCN":"万邦医药","latestPrice":46.56,"timestamp":1752735825000,"preClose":45.2,"halted":0,"volume":3095592,"delay":0,"changeRate":0.0301,"floatShares":22423000,"shares":66666700,"eps":1.0154,"marketStatus":"已收盘","change":1.36,"latestTime":"07-17 15:00:00","open":45.19,"high":46.88,"low":45.07,"amount":143000000,"amplitude":0.04,"askPrice":46.56,"askSize":41,"bidPrice":46.55,"bidSize":20,"shortable":0,"etf":0,"ttmEps":1.0154,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752802200000},"marketStatusCode":5,"adr":0,"adjPreClose":45.2,"symbolType":"stock","openAndCloseTimeList":[[1752715800000,1752723000000],[1752728400000,1752735600000]],"highLimit":49.72,"lowLimit":40.68,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":66666667,"isCdr":false,"pbRate":2.01,"roa":"--","peRate":45.853851,"roe":"0.78%","epsLYR":1.28,"committee":-0.400922,"marketValue":3104000000,"turnoverRate":0.1381,"status":0,"floatMarketCap":1044000000},"requestUrl":"/m/hq/s/301520","defaultTab":"news","newsList":[{"id":"2551917381","title":"万邦医药股价下跌1.95% 公司澄清与辉瑞、阿斯利康无合作关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2551917381","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551917381?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:30","pubTimestamp":1752604208,"startTime":"0","endTime":"0","summary":"万邦医药股价报45.31元,较前一交易日下跌0.90元。当日开盘价为45.71元,最高触及45.90元,最低下探44.35元,成交量为23988手,成交金额达1.08亿元。万邦医药属于医疗服务板块,公司专注于医药研发领域。公开资料显示,该公司总市值为30.21亿元,流通市值为10.16亿元。公司方面消息显示,万邦医药在投资者互动平台明确表示,目前与辉瑞、阿斯利康等国际制药巨头均无合作关系。该表态是针对投资者关于公司业务合作情况的询问作出的回应。资金流向数据显示,万邦医药当日主力资金净流出964.66万元。风险提示:股市有风险,投资需谨慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/16023051721498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BBT3K403.USD","LU0321505439.SGD","BK4588","BK4007","LU2417539215.USD","LU1894683348.USD","LU1066053197.SGD","LU0225771236.USD","LU0109394709.USD","LU1894683264.USD","IE000M9KFDE8.USD","BK4568","BK4585","LU0170899867.USD","SG9999001176.SGD","LU0306806265.USD","301520","IE00BLSP4239.USD","LU0122379950.USD","SG9999011175.SGD","IE00B19Z3581.USD","AZN","SG9999013999.USD","LU1023059063.AUD","SG9999002224.SGD","LU0234572021.USD","BK4592","SG9999001176.USD","LU0985481810.HKD","LU1057294990.SGD","LU2236285917.USD","LU2456880835.USD","LU0289739699.SGD","LU1829250122.USD","BK4534","LU0889565916.HKD","SGXZ57979304.SGD","LU2462157665.USD","BK4599","LU0456855351.SGD","LU0225284248.USD","LU0320765992.SGD","SG9999002232.USD","LU1883839398.USD","IE0002270589.USD","IE00BLSP4452.SGD","BK0216","LU1066051498.USD","BK4533"],"gpt_icon":0},{"id":"2544825579","title":"万邦医药:截止2025年6月10日,公司的股东人数为12,206户","url":"https://stock-news.laohu8.com/highlight/detail?id=2544825579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544825579?lang=zh_cn&edition=full","pubTime":"2025-06-17 08:54","pubTimestamp":1750121655,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问:截至到2025年6月10日贵公司的股东人数是多少?万邦医药回复:尊敬的投资者您好,截止2025年6月10日,公司的股东人数为12,206户,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700005361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2542914373","title":"【CRO概念震荡走低 联化科技跌停】CRO概念震荡走低,联化科技跌停,万邦医药、河化股份、翰宇药业、睿智医药、昭衍新药等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542914373","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542914373?lang=zh_cn&edition=full","pubTime":"2025-06-11 11:09","pubTimestamp":1749611373,"startTime":"0","endTime":"0","summary":"CRO概念震荡走低,联化科技跌停,万邦医药、河化股份、翰宇药业、睿智医药、昭衍新药等跟跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/11110950996739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0070","BK0028","000953","301520","002250","BK0239","BK0229","BK0188","603127","BK1141","300199","BK0071","06127","BK0010","BK0004","BK1576","300149","BK0077","BK0118","BK0216","BK0066"],"gpt_icon":0},{"id":"2542388571","title":"万邦医药收盘上涨8.99%,滚动市盈率44.32倍,总市值30.00亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542388571","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542388571?lang=zh_cn&edition=full","pubTime":"2025-06-09 17:56","pubTimestamp":1749463001,"startTime":"0","endTime":"0","summary":"6月9日,万邦医药今日收盘45.0元,上涨8.99%,滚动市盈率PE达到44.32倍,创139天以来新低,总市值30.00亿元。从行业市盈率排名来看,公司所处的医疗服务行业市盈率平均41.42倍,行业中值44.32倍,万邦医药排名第30位。股东方面,截至2025年3月31日,万邦医药股东户数9256户,较上次增加583户,户均持股市值35.28万元,户均持股数量2.76万股。安徽万邦医药科技股份有限公司的主营业务是为医药企业和其他医药研发机构提供专业化医药研发外包服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/09175650951699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2535351057","title":"万邦医药:公司有为改善干眼症的麦角硫因洗眼液项目提供临床功效试验服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2535351057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535351057?lang=zh_cn&edition=full","pubTime":"2025-05-16 16:06","pubTimestamp":1747382776,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)05月16日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,你好,请问贵公司有没有研究护眼用药物麦角硫因?谢谢,忘回答万邦医药回复:尊敬的投资者您好,公司有为改善干眼症的麦角硫因洗眼液项目提供临床功效试验服务,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600022589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2535358848","title":"【万邦医药:与仅三生物在麦角硫因方面有临床项目合作】万邦医药在互动平台表示,公司与仅三生物在麦角硫因方面有临床项目合作,公司为仅三生物研发的产品提供功效性验证临床服务。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535358848","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535358848?lang=zh_cn&edition=full","pubTime":"2025-05-16 14:19","pubTimestamp":1747376368,"startTime":"0","endTime":"0","summary":"万邦医药在互动平台表示,公司与仅三生物在麦角硫因方面有临床项目合作,公司为仅三生物研发的产品提供功效性验证临床服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16141950441806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2535633322","title":"万邦医药:公司研究了麦角硫因的潜在多种功效","url":"https://stock-news.laohu8.com/highlight/detail?id=2535633322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535633322?lang=zh_cn&edition=full","pubTime":"2025-05-16 11:33","pubTimestamp":1747366408,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)05月16日在投资者关系平台上答复投资者关心的问题。投资者提问:介绍一下贵公司在麦角硫因方面的研究万邦医药回复:尊敬的投资者您好,公司研究了麦角硫因的潜在多种功效,通过人体试食试验验证功效并且探索在人体内的作用机制,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600013450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2535332283","title":"万邦医药:公司与仅三生物在麦角硫因方面有临床项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2535332283","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535332283?lang=zh_cn&edition=full","pubTime":"2025-05-16 11:33","pubTimestamp":1747366408,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)05月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问贵公司是否和仅三生物在麦角硫因方面有合作?请具体介绍万邦医药回复:尊敬的投资者您好,公司与仅三生物在麦角硫因方面有临床项目合作,我公司为仅三生物研发的产品提供功效性验证临床服务,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600013449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2530157475","title":"万邦医药收盘下跌2.27%,滚动市盈率35.14倍,总市值23.79亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530157475","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530157475?lang=zh_cn&edition=full","pubTime":"2025-04-28 18:26","pubTimestamp":1745836012,"startTime":"0","endTime":"0","summary":"4月28日,万邦医药今日收盘35.68元,下跌2.27%,滚动市盈率PE达到35.14倍,总市值23.79亿元。从行业市盈率排名来看,公司所处的医疗服务行业市盈率平均40.74倍,行业中值42.36倍,万邦医药排名第27位。资金流向方面,4月28日,万邦医药主力资金净流出265.02万元,近5日总体呈流出状态,5日共流出1697.32万元。安徽万邦医药科技股份有限公司的主营业务是为医药企业和其他医药研发机构提供专业化医药研发外包服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/28182649959933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2529180356","title":"万邦医药(301520.SZ)发布2024年度业绩,归母净利润8553.07万元,下降20.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529180356","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529180356?lang=zh_cn&edition=full","pubTime":"2025-04-21 19:52","pubTimestamp":1745236320,"startTime":"0","endTime":"0","summary":"万邦医药(301520.SZ)发布2024年年度报告,该公司营业收入为3.79亿元,同比增长10.91%。归属于上市公司股东的净利润为8553.07万元,同比减少20.87%。归属于上市公司股东的扣除非经常性损益的净利润为5578.78万元,同比减少42.90%。基本每股收益为1.28元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-21/doc-inetxsmq8551293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301520"],"gpt_icon":0},{"id":"2529870456","title":"万邦医药(301520.SZ)发布一季度业绩,归母净利润1184.93万元,下降60.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529870456","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529870456?lang=zh_cn&edition=full","pubTime":"2025-04-21 19:49","pubTimestamp":1745236175,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万邦医药(301520.SZ)发布2025年第一季度报告,该公司营业收入为7105.22万元,同比减少21.20%。归属于上市公司股东的净利润为1184.93万元,同比减少60.09%。归属于上市公司股东的扣除非经常性损益的净利润为535.89万元,同比减少76.44%。基本每股收益为0.18元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301520"],"gpt_icon":0},{"id":"2514933344","title":"万邦医药最新公告:证券事务代表杨婷因个人原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2514933344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514933344?lang=zh_cn&edition=full","pubTime":"2025-02-28 18:30","pubTimestamp":1740738611,"startTime":"0","endTime":"0","summary":"万邦医药(301520.SZ)公告称,公司董事会近日收到证券事务代表杨婷的书面辞职报告,杨婷因个人原因申请辞去公司证券事务代表职务。杨婷的辞职不会影响公司相关工作的正常开展,公司将尽快聘任新的证券事务代表。杨婷在任职期间恪尽职守、勤勉尽责,公司对其表示感谢。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800036185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","161027","301520"],"gpt_icon":0},{"id":"2514508486","title":"万邦医药上涨5.09%,报44.99元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514508486","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514508486?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:41","pubTimestamp":1740447683,"startTime":"0","endTime":"0","summary":"2月25日,万邦医药盘中上涨5.09%,截至09:41,报44.99元/股,成交6665.68万元,换手率6.87%,总市值29.99亿元。资料显示,安徽万邦医药科技股份有限公司位于安徽省合肥市高新区火龙地路299号,公司是一家成立于2006年的医药科技公司,主要业务涉及医药外包等领域。该公司在业内获得了国家高新技术企业、中国医药外包公司20强等多个荣誉,显示了其在医药科技领域的领先地位。截至12月31日,万邦医药股东户数8673,人均流通股2545股。2024年1月-9月,万邦医药实现营业收入2.93亿元,同比增长21.88%;归属净利润7779.75万元,同比增长0.63%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/25094148362148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2511866081","title":"万邦医药:公司在药物研发过程中暂未使用AI技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2511866081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511866081?lang=zh_cn&edition=full","pubTime":"2025-02-14 21:00","pubTimestamp":1739538027,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)02月14日在投资者关系平台上答复投资者关心的问题。投资者:问一下公司新药研发采用什么手段,目前是否应用了AI?万邦医药董秘:回答:尊敬的投资者您好,公司在药物研发过程中暂未使用AI技术。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400040237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2503134541","title":"万邦医药:关于加大现金分红及转增股本的具体方案将综合考虑后制定","url":"https://stock-news.laohu8.com/highlight/detail?id=2503134541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503134541?lang=zh_cn&edition=full","pubTime":"2025-01-14 17:30","pubTimestamp":1736847034,"startTime":"0","endTime":"0","summary":"关于加大现金分红及转增股本的具体方案,公司董事会会根据《公司章程》及相关法律法规的要求,结合公司经营状况和财务状况,综合考虑后制定相应的利润分配方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011400030266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"gpt_icon":0},{"id":"2502012069","title":"万邦医药:公司临床试验研究及药学研究的项目中有涉及呼吸道感染相关的药品,例如氨茶碱片等,但公司不涉及生产及销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2502012069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502012069?lang=zh_cn&edition=full","pubTime":"2025-01-09 15:30","pubTimestamp":1736407822,"startTime":"0","endTime":"0","summary":"证券之星消息,万邦医药(301520)01月09日在投资者关系平台上答复投资者关心的问题。投资者:董秘您好,请问公司有流感,感冒方面的产品和业务吗?万邦医药董秘:尊敬的投资者您好,公司临床试验研究及药学研究的项目中有涉及呼吸道感染相关的药品,例如氨茶碱片等,但公司不涉及生产及销售。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010900019421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0216","301520","BK1141","BK1576","03347"],"gpt_icon":0},{"id":"2500936917","title":"1月2日万邦医药现1笔折价18.69%的大宗交易 合计成交1833.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500936917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500936917?lang=zh_cn&edition=full","pubTime":"2025-01-02 17:01","pubTimestamp":1735808493,"startTime":"0","endTime":"0","summary":"证券之星消息,1月2日万邦医药发生大宗交易,交易数据如下:大宗交易成交价格30.81元,相对当日收盘价折价18.69%,成交59.5万股,成交金额1833.2万元,买方营业部为中信证券股份有限公司上海宝山区同济路证券营业部,卖方营业部为华泰证券股份有限公司扬州高邮屏淮路证券营业部。近三个月该股共发生2笔大宗交易,合计成交1.29万手,折价成交2笔。截至2025年1月2日收盘,万邦医药报收于37.89元,下跌1.58%,换手率3.2%,成交量7056.0手,成交额2712.76万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010200022650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"gpt_icon":0},{"id":"2500917352","title":"万邦医药1月2日现1笔大宗交易 成交金额1833.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500917352","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500917352?lang=zh_cn&edition=full","pubTime":"2025-01-02 16:40","pubTimestamp":1735807200,"startTime":"0","endTime":"0","summary":" 1月2日,万邦医药收跌1.58%,收盘价为37.89元,发生1笔大宗交易,合计成交量59.5万股,成交金额1833.2万元。 进一步统计,近3个月内该股累计发生2笔大宗交易,合计成交金额为4099.1万元。该股近5个交易日累计下跌6.67%,主力资金合计净流出717.81万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-01-02/doc-inecqnpz2384367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301520","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752769850456,"stockEarnings":[{"period":"1week","weight":0.037},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.2128},{"period":"6month","weight":0.2412},{"period":"1year","weight":0.1772},{"period":"ytd","weight":0.2206}],"compareEarnings":[{"period":"1week","weight":0.002},{"period":"1month","weight":0.0382},{"period":"3month","weight":0.0733},{"period":"6month","weight":0.0848},{"period":"1year","weight":0.187},{"period":"ytd","weight":0.0492}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽万邦医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"12206人(较上一季度增加33.79%)","perCapita":"1837股","listingDate":"2023-09-25","address":"安徽省合肥市蜀山区高新区火龙地路299号","registeredCapital":"6666万元","survey":" 安徽万邦医药科技股份有限公司的主营业务是为医药企业和其他医药研发机构提供专业化医药研发外包服务。公司的主要产品是临床试验现场管理(SMO)、生物样本分析(BA)、数据管理与统计分析(DM/ST)、处方工艺研究、质量研究、稳定性研究。","listedPrice":67.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万邦医药,301520,万邦医药股票,万邦医药股票老虎,万邦医药股票老虎国际,万邦医药行情,万邦医药股票行情,万邦医药股价,万邦医药股市,万邦医药股票价格,万邦医药股票交易,万邦医药股票购买,万邦医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}